{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T03:28:30Z","timestamp":1777260510951,"version":"3.51.4"},"reference-count":41,"publisher":"Japanese Circulation Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,9,25]]},"DOI":"10.1253\/circj.cj-24-0690","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T18:07:07Z","timestamp":1744049227000},"page":"1652-1661","source":"Crossref","is-referenced-by-count":2,"title":["Relationships Between Cumulative Resting Heart Rate and the Incidence of Cardiovascular Events and All-Cause Mortality\u3000\u2015 Post Hoc Analysis of STEP Trial Data \u2015"],"prefix":"10.1253","volume":"89","author":[{"given":"Run","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College"},{"name":"Shantou University Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianhui","family":"Ling","sequence":"additional","affiliation":[{"name":"Hypertension Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease of China, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College"},{"name":"Shantou University Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College"},{"name":"Shantou University Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College"},{"name":"Shantou University Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangshuang","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College"},{"name":"Shantou University Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[{"name":"Hypertension Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease of China, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jilin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youren","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019. <i>J Am Coll Cardiol<\/i> 2020; 76: 2982\u20133021.","DOI":"10.1016\/j.jacc.2020.11.010"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wei D, Xiao W, Zhou L, Guo J, Lu W, Wang Y. Age-period-cohort analysis of ischemic heart disease morbidity and mortality in China, 1990\u20132019. <i>Circ J<\/i> 2022; 86: 1437\u20131443.","DOI":"10.1253\/circj.CJ-21-0749"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. <i>Lancet<\/i> 2020; 396: 1223\u20131249.","DOI":"10.1016\/S0140-6736(20)30752-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks. <i>J Am Coll Cardiol<\/i> 2020; 76: 2980\u20132981.","DOI":"10.1016\/j.jacc.2020.11.021"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kubo K, Hirata A, Kadota A, Harada A, Nakamura Y, Hayakawa T, et al. Risk factors for heart failure and coronary artery disease mortality based on the National Vital Statistics during a 25-year follow-up in Japan: NIPPON DATA90. <i>Circ J<\/i> 2024; 88: 1478\u20131487.","DOI":"10.1253\/circj.CJ-23-0847"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Suzuki Y, Kaneko H, Okada A, Fujiu K, Takeda N, Morita H, et al. BP classification using the 2017 ACC\/AHA BP guidelines with risk of cardiovascular events in older individuals. <i>J Cardiol<\/i> 2024; 84: 394\u2013403.","DOI":"10.1016\/j.jjcc.2024.07.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. <i>Lancet<\/i> 2021; 398: 957\u2013980.","DOI":"10.1016\/S0140-6736(21)01330-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zhang W, Zhang S, Deng Y, Wu S, Ren J, Sun G, et al. Trial of intensive blood-pressure control in older patients with hypertension. <i>N Engl J Med<\/i> 2021; 385: 1268\u20131279.","DOI":"10.1056\/NEJMoa2111437"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Morcet JF, Safar M, Thomas F, Guize L, Benetos A. Associations between heart rate and other risk factors in a large French population. <i>J Hypertens<\/i> 1999; 17: 1671\u20131676.","DOI":"10.1097\/00004872-199917120-00003"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Palatini P. Role of elevated heart rate in the development of cardiovascular disease in hypertension. <i>Hypertension<\/i> 2011; 58: 745\u2013750.","DOI":"10.1161\/HYPERTENSIONAHA.111.173104"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gillman MW, Kannel WB, Belanger A, D\u2019Agostino RB. Influence of heart rate on mortality among persons with hypertension: The Framingham Study. <i>Am Heart J<\/i> 1993; 125: 1148\u20131154.","DOI":"10.1016\/0002-8703(93)90128-V"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Julius S, Palatini P, Kjeldsen SE, Zanchetti A, Weber MA, McInnes GT, et al. Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. <i>Am J Cardiol<\/i> 2012; 109: 685\u2013692.","DOI":"10.1016\/j.amjcard.2011.10.025"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Li K, Yao C, Yang X, Dong L. Effect of resting heart rate on all-cause mortality and cardiovascular events according to age. <i>J Am Geriatr Soc<\/i> 2017; 65: 989\u2013994.","DOI":"10.1111\/jgs.14714"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sobieraj P, Si\u0144ski M, Lewandowski J. Resting heart rate and cardiovascular outcomes during intensive and standard blood pressure reduction: An analysis from SPRINT trial. <i>J Clin Med<\/i> 2021; 10: 3264.","DOI":"10.3390\/jcm10153264"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Jenkins LM, Garner CR, Kurian S, Higgins JP, Parrish TB, Sedaghat S, et al. Cumulative blood pressure exposure, basal ganglia, and thalamic morphology in midlife. <i>Hypertension<\/i> 2020; 75: 1289\u20131295.","DOI":"10.1161\/HYPERTENSIONAHA.120.14678"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Huang Y, Zhou H, Zhang S, Zhong X, Lin Y, Xiong Z, et al. Mid- to late-life time-averaged cumulative blood pressure and late-life retinal microvasculature: The ARIC study. <i>J Am Heart Assoc<\/i> 2022; 11: e25226.","DOI":"10.1161\/JAHA.122.025226"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tian X, Wang A, Wu S, Zuo Y, Chen S, Zhang L, et al. Cumulative serum uric acid and its time course are associated with risk of myocardial infarction and all-cause mortality. <i>J Am Heart Assoc<\/i> 2021; 10: e020180.","DOI":"10.1161\/JAHA.120.020180"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wang X, Feng B, Huang Z, Cai Z, Yu X, Chen Z, et al. Relationship of cumulative exposure to the triglyceride-glucose index with ischemic stroke: A 9-year prospective study in the Kailuan cohort. <i>Cardiovasc Diabetol<\/i> 2022; 21: 66.","DOI":"10.1186\/s12933-022-01510-y"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zhang S, Wu S, Ren J, Chen X, Zhang X, Feng Y, et al. Strategy of blood pressure intervention in the elderly hypertensive patients (STEP): Rational, design, and baseline characteristics for the main trial. <i>Contemp Clin Trials<\/i> 2020; 89: 105913.","DOI":"10.1016\/j.cct.2019.105913"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. D\u2019Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. <i>Circulation<\/i> 2008; 117: 743\u2013753.","DOI":"10.1161\/CIRCULATIONAHA.107.699579"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Zang EA, Wynder EL. Cumulative tar exposure. A new index for estimating lung cancer risk among cigarette smokers. <i>Cancer<\/i> 1992; 70: 69\u201376.","DOI":"10.1002\/1097-0142(19920701)70:1<69::AID-CNCR2820700112>3.0.CO;2-A"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yu J, Dai L, Zhao Q, Liu X, Chen S, Wang A, et al. Association of cumulative exposure to resting heart rate with risk of stroke in general population: The Kailuan cohort study. <i>J Stroke Cerebrovasc Dis<\/i> 2017; 26: 2501\u20132509.","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.05.037"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mancia G, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. <i>Eur Heart J<\/i> 2018; 39: 3021\u20133104.","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kolloch R, Legler UF, Champion A, Cooper-DeHoff RM, Handberg E, Zhou Q, et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: Findings from the INternational VErapamil-SR\/trandolapril STudy (INVEST). <i>Eur Heart J<\/i> 2007; 29: 1327\u20131334.","DOI":"10.1093\/eurheartj\/ehn123"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Okin PM, Kjeldsen SE, Julius S, Hille DA, Dahlof B, Edelman JM, et al. All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy. <i>Eur Heart J<\/i> 2010; 31: 2271\u20132279.","DOI":"10.1093\/eurheartj\/ehq225"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Paul L, Hastie CE, Li WS, Harrow C, Muir S, Connell JMC, et al. Resting heart rate pattern during follow-up and mortality in hypertensive patients. <i>Hypertension<\/i> 2010; 55: 567\u2013574.","DOI":"10.1161\/HYPERTENSIONAHA.109.144808"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Grassi G, Quarti-Trevano F, Seravalle G, Dell\u2019Oro R, Facchetti R, Mancia G. Association between the European Society of Cardiology\/European Society of Hypertension heart rate thresholds for cardiovascular risk and neuroadrenergic markers. <i>Hypertension<\/i> 2020; 76: 577\u2013582.","DOI":"10.1161\/HYPERTENSIONAHA.120.14804"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Whelton SP, Blankstein R, Al-Mallah MH, Lima JAC, Bluemke DA, Hundley WG, et al. Association of resting heart rate with carotid and aortic arterial stiffness: Multi-Ethnic Study of Atherosclerosis. <i>Hypertension<\/i> 2013; 62: 477\u2013484.","DOI":"10.1161\/HYPERTENSIONAHA.113.01605"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Whelton SP, Narla V, Blaha MJ, Nasir K, Blumenthal RS, Jenny NS, et al. Association between resting heart rate and inflammatory biomarkers (high-sensitivity C-reactive protein, interleukin-6, and fibrinogen) (from the Multi-Ethnic Study of Atherosclerosis). <i>Am J Cardiol<\/i> 2014; 113: 644\u2013649.","DOI":"10.1016\/j.amjcard.2013.11.009"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. B\u00f6hm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, et al. Heart rate as a risk factor in chronic heart failure (SHIFT): The association between heart rate and outcomes in a randomised placebo-controlled trial. <i>Lancet<\/i> 2010; 376: 886\u2013894.","DOI":"10.1016\/S0140-6736(10)61259-7"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Oba Y, Kabutoya T, Kohro T, Imai Y, Kario K, Sato H, et al. Relationships among heart rate, \u03b2-blocker dosage, and prognosis in patients with coronary artery disease in a real-world database using a multimodal data acquisition system. <i>Circ J<\/i> 2023; 87: 336\u2013344.","DOI":"10.1253\/circj.CJ-22-0314"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Fox K, Ford I, Steg PG, Tendera M, Ferrari R. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A randomised, double-blind, placebo-controlled trial. <i>Lancet<\/i> 2008; 372: 807\u2013816.","DOI":"10.1016\/S0140-6736(08)61170-8"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Sun N, Chen Y, Xi Y, Wang H, Wang L. Association between heart rate and major adverse cardiovascular events among 9,991 hypertentive patients: A multicenter retrospective follow-up study. <i>Front Cardiovasc Med<\/i> 2021; 8: 741784.","DOI":"10.3389\/fcvm.2021.741784"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. B\u00f6hm M, Schumacher H, Linz D, Reil JC, Ukena C, Lonn E, et al. Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: Results of the ONTARGET\/TRANSCEND studies. <i>J Intern Med<\/i> 2015; 278: 303\u2013312.","DOI":"10.1111\/joim.12373"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK, et al. Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: An analysis of ONTARGET\/TRANSCEND. <i>Clin Res Cardiol<\/i> 2014; 103: 149\u2013159.","DOI":"10.1007\/s00392-013-0644-4"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Ferrari R, Fox K. Heart rate reduction in coronary artery disease and heart failure. <i>Nat Rev Cardiol<\/i> 2016; 13: 493\u2013501.","DOI":"10.1038\/nrcardio.2016.84"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Palatini P. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. <i>Arch Intern Med<\/i> 2002; 162: 2313.","DOI":"10.1001\/archinte.162.20.2313"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Bangalore S, Sawhney S, Messerli FH. Relation of Beta-blocker\u2013induced heart rate lowering and cardioprotection in hypertension. <i>J Am Coll Cardiol<\/i> 2008; 52: 1482\u20131489.","DOI":"10.1016\/j.jacc.2008.06.048"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Dahl\u00f6f B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. <i>Lancet<\/i> 2002; 359: 995\u20131003.","DOI":"10.1016\/S0140-6736(02)08089-3"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Dahl\u00f6f B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. <i>Lancet<\/i> 2005; 366: 895\u2013906.","DOI":"10.1016\/S0140-6736(05)67185-1"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Zhang Y, Sun N, Jiang X, Xi Y. Comparative efficacy of \u03b2-blockers on mortality and cardiovascular outcomes in patients with hypertension: A systematic review and network meta-analysis. <i>J Am Soc Hypertens<\/i> 2017; 11: 394\u2013401.","DOI":"10.1016\/j.jash.2017.05.001"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/10\/89_CJ-24-0690\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T03:37:17Z","timestamp":1758944237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/10\/89_CJ-24-0690\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-24-0690","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"article-number":"CJ-24-0690"}}